Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

Discover how cfDNA fragmentome tests could help detect liver disease early and track health. Learn more about this emerging ...

Researchers report that the integration of machine learning and Internet of Things (IoT) technologies is enabling a new generation of intelligent industrial environments capable of real-time ...

Inside a diseased cell, the genes are in chaos. Some are receiving signals to overproduce a protein. Others are reducing ...

There are more candidates on the waitlist for a liver transplant than there are available organs, yet about half the time a match is found with a donor who dies after cardiac arrest following ...

Discover how AI startups are driving rapid AI industry disruption across healthcare, finance, marketing, and more—redefining innovation, efficiency, and the future of global industries.

EpiTracing" has proved capable of detecting and tracing diseases from as little as 50 μl of human plasma, roughly a drop of ...

Researchers developed prediction models to identify premature infants with bronchopulmonary dysplasia who are at risk of ...

In the management of Crohn’s disease, a key objective — preserving the bowel by reducing the need for multiple resections — ...

IBB and other biotech ETFs are gaining traction as AI reshapes drug discovery, genomics, and clinical trials, giving investors diversified exposure to biotech innovation.

An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing ...